Literature DB >> 18501420

Metabolic syndrome--what is the clinical usefulness?

Richard Kahn1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18501420     DOI： 10.1016/S0140-6736(08)60731-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  26 in total

1.  Analysis of metabolic syndrome components in >15 000 african americans identifies pleiotropic variants: results from the population architecture using genomics and epidemiology study.

Authors:  Cara L Carty; Samsiddhi Bhattacharjee; Jeff Haessler; Iona Cheng; Lucia A Hindorff; Vanita Aroda; Christopher S Carlson; Chun-Nan Hsu; Lynne Wilkens; Simin Liu; Elizabeth Selvin; Rebecca Jackson; Kari E North; Ulrike Peters; James S Pankow; Nilanjan Chatterjee; Charles Kooperberg
Journal:  Circ Cardiovasc Genet       Date:  2014-07-14

Review 2.  Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence.

Authors:  Silvia Lorente-Cebrián; André G V Costa; Santiago Navas-Carretero; María Zabala; J Alfredo Martínez; María J Moreno-Aliaga
Journal:  J Physiol Biochem       Date:  2013-06-22       Impact factor: 4.158

3.  Rhesus macaques develop metabolic syndrome with reversible vascular dysfunction responsive to pioglitazone.

Authors:  Xiuqin Zhang; Rongli Zhang; Susanne Raab; Wen Zheng; Jue Wang; Na Liu; Tiangang Zhu; Lifang Xue; Zhentao Song; Jiaming Mao; Kaitao Li; Huiliang Zhang; Yan Zhang; Chao Han; Yi Ding; Hui Wang; Ning Hou; Yuli Liu; Shujiang Shang; Chuanyun Li; Elena Sebokova; Heping Cheng; Paul L Huang
Journal:  Circulation       Date:  2011-06-20       Impact factor: 29.690

Review 4.  Vascular biology of metabolic syndrome.

Authors:  Daynene Vykoukal; Mark G Davies
Journal:  J Vasc Surg       Date:  2011-03-24       Impact factor: 4.268

5.  Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet.

Authors:  Jeff S Volek; Stephen D Phinney; Cassandra E Forsythe; Erin E Quann; Richard J Wood; Michael J Puglisi; William J Kraemer; Doug M Bibus; Maria Luz Fernandez; Richard D Feinman
Journal:  Lipids       Date:  2008-12-12       Impact factor: 1.880

6.  "The metabolic syndrome... is dead": these reports are an exaggeration.

Authors:  Alexander Tenenbaum; Enrique Z Fisman
Journal:  Cardiovasc Diabetol       Date:  2011-01-27       Impact factor: 9.951

7.  Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Authors:  Russell Scott; Richard O'Brien; Greg Fulcher; Chris Pardy; Michael D'Emden; Dana Tse; Marja-Riitta Taskinen; Christian Ehnholm; Anthony Keech
Journal:  Diabetes Care       Date:  2008-11-04       Impact factor: 19.112

8.  Impact of metabolic syndrome compared with impaired fasting glucose on the development of type 2 diabetes in a general Japanese population: the Hisayama study.

Authors:  Naoko Mukai; Yasufumi Doi; Toshiharu Ninomiya; Jun Hata; Koji Yonemoto; Masanori Iwase; Mitsuo Iida; Yutaka Kiyohara
Journal:  Diabetes Care       Date:  2009-09-03       Impact factor: 17.152

9.  Subhealth: definition, criteria for diagnosis and potential prevalence in the central region of China.

Authors:  Guolin Li; Fuxia Xie; Siyu Yan; Xiaofei Hu; Bo Jin; Jun Wang; Jinfeng Wu; Dazhong Yin; Qingji Xie
Journal:  BMC Public Health       Date:  2013-05-04       Impact factor: 3.295

10.  Periodontal disease: the influence of metabolic syndrome.

Authors:  Enrico Marchetti; Simona Tecco; Annalisa Monaco; Laura Procaccini; Stefano Mummolo; Roberto Gatto; Stefano Tetè; Alberto Baldini; Giuseppe Marzo
Journal:  Nutr Metab (Lond)       Date:  2012-09-25       Impact factor: 4.169
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.